Parkinson's Disease: A Comparative Study of Levodopa and Carbidopa Bioavailability Following Foslevodopa/Foscarbidopa Infusion at Different Subcutaneous Sites in Parkinson's Disease Patients
Latest Information Update: 27 Mar 2023
At a glance
- Drugs Foscarbidopa/Foslevodopa (Primary)
- Indications Parkinson's disease
- Focus Pharmacokinetics
- Sponsors AbbVie
Most Recent Events
- 22 Mar 2023 Status changed from active, no longer recruiting to completed.
- 08 Mar 2023 Planned End Date changed from 27 Jun 2023 to 18 Mar 2023.
- 08 Mar 2023 Planned primary completion date changed from 27 Jun 2023 to 18 Mar 2023.